Discover how colonoscopy surveillance programs are revolutionizing cancer prevention for IBD patients through a decade-long medical study.
Discover how Fusobacterium nucleatum, a common oral bacterium, drives colorectal cancer metastasis to the liver by manipulating immune responses and creating a hospitable environment for cancer growth.
Explore the groundbreaking phase 1 dose-escalation study of linclatamig, a LY6G6D×CD3 T cell-engaging bispecific antibody for colorectal cancer treatment.
Discover how Lactobacillus coryniformis MXJ32, a probiotic from fermented foods, shows promise in preventing colorectal cancer by strengthening gut barriers and reducing inflammation.
Exploring the connection between dietary inflammation, obesity, and colorectal cancer risk through groundbreaking Malaysian research.